Business Wire

Connected Objects: a Global Ambition at Total

Jaa

Oil and gas company Total has joined forces with Sigfox, the world’s leading IoT connectivity service, to deploy a solution designed to optimise rolling stock and help manage trailer fleets.

What’s the solution?

Created by transporters, for transporters, Where’s my Trailer? is an innovative new way to improve how trailer fleets are used and kept secure.

The solution works by installing a box on the trailer, to identify any equipment that is underused or has been lost or stolen.

Our partnership

Total group has signed a global partnership with Sigfox. The solution was developed by Total Marketing France through its subsidiary Stela and has been in test phase for a year with the company’s transporter customers.

“Sigfox technology, together with our proximity to Freight and Logistics, has given us the opportunity to offer a reliable and efficient way of geolocalising rolling stock throughout Europe,” explains Benoît Luc, Director of Total’s European Marketing & Services Department.

“We are delighted with how the Total project has developed,” adds Patrick Cason, Managing Director of Sigfox France. “The significant size of the Total group has in no way hindered our progress, in fact quite the opposite. We have seen how its full force can really benefit innovation. The group knows how to listen to its customers, how to think about their experience as users, and how to commit to providing innovative services. Our teams worked together very easily because Total both responds and makes decisions promptly.”

How it works

The boxes are self-powered and very easy to install on the trailer. They communicate using Sigfox technology, which is able to provide a low bandwidth connection network at a very low cost.

Where’s my Trailer? localises any stationery trailers and allows users to set up notifications. Messages are displayed on the secure customer portal, which can be accessed from the websites stela.fr and as24.com,and are compatible with all digital devices.

Maps and dashboards provide information on:

  • Trailers and a track record of inactive periods
  • Tractor-trailer pairing – drop-and-hook detection
  • Maintenance – vehicle safety inspection, repairs
  • Unauthorised movement during time periods can be configured by the customer

How to access the service

Where’s My Trailer? is easy to deploy and use, and is very competitively priced on the transport market.

This solution marks the end of high costs and complex systems: benefiting from Sigfox’s services and international network, this disruptive solution both significantly reduces costs and simplifies the system’s implementation, unlike current solutions that are complex to deploy.

It will be available from July 9, 2018, first in France and then in Europe, through Stela and AS24. There will also be a hotline open 5 days a week, to help customers install their boxes, use the secure portal, and configure their options. Where’s my Trailer? is free to download – the only requirement is to purchase a subscription.

The solution is scalable and will soon include new features.

Please note

This press release is for informational purposes only and shall have no legal consequences. The entities in which TOTAL SA directly or indirectly owns a stake are separate and autonomous. TOTAL SA shall not be held liable for the actions or omissions of the aforementioned companies. The terms “TOTAL”, “TOTAL Group” and “Group” as presented in this document are generic and used for convenience only. Similarly, the terms “we”, “us” and “our” may also be used to refer to subsidiaries or employees of those subsidiaries.

This document may contain forward-looking information and statements that are based on economic data and assumptions made based on a particular economic, competitive and regulatory context. They may prove inaccurate in the future and are dependent on risk factors. Neither TOTAL SA nor any of its affiliates make any commitment or take on any responsibility in relation to investors or any other party to update or revise any or all statements, forward-looking information, trends or objectives contained in this document, especially as a result of new information or future events.

Contact information

Sigfox
Eleanor Burgess +44 (0)7773931979
or
Sales relations:
ingrid.aeck@stela.fr

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme